General and Administrative (G&A) Expenses. G&A expenses for the three months ended March 31, 2025 were $6.9 million compared to $5.1 million for the same period in 2024. The increase was primarily ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Charles River Laboratories International Inc. $136.97 21.56 18.68% ...

Visit a quote page and your recently viewed tickers will be displayed here.